Detalhe da pesquisa
1.
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
N Engl J Med
; 375(19): 1845-1855, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717298
2.
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 18(3): 393-403, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28162999
3.
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 16(5): 522-30, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25840693
4.
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
N Engl J Med
; 364(22): 2119-27, 2011 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21631324
5.
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.
J Transl Med
; 8: 89, 2010 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20875102
6.
Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy.
J Oncol Pract
; 15(12): e1076-e1084, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573829
7.
Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.
Eur J Cancer
; 119: 1-10, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31400634
8.
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.
J Immunother Cancer
; 6(1): 44, 2018 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848375
9.
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
Nat Rev Clin Oncol
; 10(10): 588-98, 2013 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982524
10.
Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
Cancer
; 115(22): 5228-36, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19728370
11.
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
J Clin Oncol
; 25(15): 2078-85, 2007 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17513813